measles virus vaccine, live, attenuated (Attenuvax)

From Aaushi
Jump to navigation Jump to search

Epidemiology

Indications

Contraindications

Caution:

Dosage

Children > 15 months & adults: 0.5 mL SC

Injection: 1000 TCID50 per dose

Adverse effects

Vaccine interactions:

Test interactions

More general terms

Additional terms

Component of

References

  1. Kaiser Permanente Northern California Regional Drug Formulary, 1998
  2. 2.0 2.1 Rowhani-Rahbar A et al. Effect of age on the risk of fever and seizures following immunization with measles-containing vaccines in children. JAMA Pediatr 2013 Oct 14 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24126936 <Internet> http://archpedi.jamanetwork.com/article.aspx?articleid=1750204
    Feemster KA and Offit P. Delaying vaccination is not a safer choice. JAMA Pediatr 2013 Oct 14 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24126848 <Internet> http://archpedi.jamanetwork.com/article.aspx?articleid=1750202
  3. 3.0 3.1 Lo NC, Hotez PJ Public Health and Economic Consequences of Vaccine Hesitancy for Measles in the United States. JAMA Pediatr. Published online July 24, 2017 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/28738137 <Internet> http://jamanetwork.com/journals/jamapediatrics/fullarticle/2643169